Annual Net Income
-$11.76 M
+$10.06 M+46.11%
December 1, 2023
Summary
- As of February 7, 2025, ADXN annual net profit is -$11.76 million, with the most recent change of +$10.06 million (+46.11%) on December 1, 2023.
- During the last 3 years, ADXN annual net income has risen by +$1.96 million (+14.29%).
- ADXN annual net income is now -599.19% below its all-time high of -$1.68 million, reached on December 31, 2018.
Performance
ADXN Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$1.77 M
-$16.01 M-112.42%
September 1, 2024
Summary
- As of February 7, 2025, ADXN quarterly net profit is -$1.77 million, with the most recent change of -$16.01 million (-112.42%) on September 1, 2024.
- Over the past year, ADXN quarterly net income has increased by +$1.19 million (+40.29%).
- ADXN quarterly net income is now -112.42% below its all-time high of $14.24 million, reached on June 1, 2024.
Performance
ADXN Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
$5.72 M
+$1.19 M+26.41%
September 1, 2024
Summary
- As of February 7, 2025, ADXN TTM net profit is $5.72 million, with the most recent change of +$1.19 million (+26.41%) on September 1, 2024.
- Over the past year, ADXN TTM net income has increased by +$18.05 million (+146.34%).
- ADXN TTM net income is now at all-time high.
Performance
ADXN TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
ADXN Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +46.1% | +40.3% | +146.3% |
3 y3 years | +14.3% | +63.1% | +134.1% |
5 y5 years | -599.2% | +51.4% | +138.4% |
ADXN Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +46.1% | -112.4% | +76.3% | at high | +125.0% |
5 y | 5-year | at high | +46.1% | -112.4% | +76.3% | at high | +125.0% |
alltime | all time | -599.2% | +70.2% | -112.4% | +76.3% | at high | +125.0% |
Addex Therapeutics Ltd Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$1.77 M(-112.4%) | $5.72 M(+26.4%) |
Jun 2024 | - | $14.24 M(-503.1%) | $4.52 M(-135.6%) |
Mar 2024 | - | -$3.53 M(+9.6%) | -$12.70 M(+7.9%) |
Dec 2023 | -$11.76 M(-46.1%) | -$3.22 M(+8.8%) | -$11.76 M(-4.6%) |
Sep 2023 | - | -$2.96 M(-0.4%) | -$12.33 M(-9.5%) |
Jun 2023 | - | -$2.98 M(+14.5%) | -$13.62 M(-24.9%) |
Mar 2023 | - | -$2.60 M(-31.5%) | -$18.13 M(-17.0%) |
Dec 2022 | -$21.81 M(+29.9%) | -$3.79 M(-10.8%) | -$21.84 M(-4.4%) |
Sep 2022 | - | -$4.25 M(-43.2%) | -$22.84 M(+1.5%) |
Jun 2022 | - | -$7.48 M(+18.7%) | -$22.51 M(+11.6%) |
Mar 2022 | - | -$6.31 M(+31.4%) | -$20.17 M(+20.2%) |
Dec 2021 | -$16.80 M(+22.5%) | -$4.80 M(+22.4%) | -$16.79 M(+17.1%) |
Sep 2021 | - | -$3.92 M(-23.9%) | -$14.34 M(+2.3%) |
Jun 2021 | - | -$5.15 M(+76.5%) | -$14.02 M(+15.8%) |
Mar 2021 | - | -$2.92 M(+24.1%) | -$12.10 M(-11.2%) |
Dec 2020 | -$13.72 M | -$2.35 M(-34.7%) | -$13.64 M(-9.0%) |
Sep 2020 | - | -$3.60 M(+11.5%) | -$14.98 M(-0.2%) |
Jun 2020 | - | -$3.23 M(-27.4%) | -$15.01 M(-7.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2020 | - | -$4.45 M(+20.5%) | -$16.27 M(+9.4%) |
Dec 2019 | -$14.88 M(+784.8%) | -$3.69 M(+1.5%) | -$14.87 M(+33.0%) |
Sep 2019 | - | -$3.64 M(-18.9%) | -$11.18 M(+48.3%) |
Jun 2019 | - | -$4.49 M(+47.0%) | -$7.54 M(+147.0%) |
Mar 2019 | - | -$3.05 M | -$3.05 M |
Dec 2018 | -$1.68 M(-49.5%) | - | - |
Dec 2017 | -$3.33 M(+4.2%) | - | - |
Dec 2016 | -$3.20 M(-26.8%) | - | - |
Dec 2015 | -$4.37 M(+125.0%) | - | - |
Dec 2014 | -$1.94 M(-87.6%) | - | - |
Dec 2013 | -$15.61 M(-45.0%) | - | - |
Dec 2012 | -$28.38 M(-19.5%) | - | - |
Dec 2011 | -$35.25 M(+9.7%) | - | - |
Dec 2010 | -$32.14 M(-18.5%) | - | - |
Dec 2009 | -$39.44 M(+93.0%) | - | - |
Dec 2008 | -$20.43 M(-30.2%) | - | - |
Dec 2007 | -$29.26 M(+78.3%) | - | - |
Dec 2006 | -$16.41 M | - | - |
FAQ
- What is Addex Therapeutics Ltd annual net profit?
- What is the all time high annual net income for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd annual net income year-on-year change?
- What is Addex Therapeutics Ltd quarterly net profit?
- What is the all time high quarterly net income for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd quarterly net income year-on-year change?
- What is Addex Therapeutics Ltd TTM net profit?
- What is the all time high TTM net income for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd TTM net income year-on-year change?
What is Addex Therapeutics Ltd annual net profit?
The current annual net income of ADXN is -$11.76 M
What is the all time high annual net income for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high annual net profit is -$1.68 M
What is Addex Therapeutics Ltd annual net income year-on-year change?
Over the past year, ADXN annual net profit has changed by +$10.06 M (+46.11%)
What is Addex Therapeutics Ltd quarterly net profit?
The current quarterly net income of ADXN is -$1.77 M
What is the all time high quarterly net income for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high quarterly net profit is $14.24 M
What is Addex Therapeutics Ltd quarterly net income year-on-year change?
Over the past year, ADXN quarterly net profit has changed by +$1.19 M (+40.29%)
What is Addex Therapeutics Ltd TTM net profit?
The current TTM net income of ADXN is $5.72 M
What is the all time high TTM net income for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high TTM net profit is $5.72 M
What is Addex Therapeutics Ltd TTM net income year-on-year change?
Over the past year, ADXN TTM net profit has changed by +$18.05 M (+146.34%)